" /> Resminostat - CISMeF





Preferred Label : Resminostat;

NCIt definition : An orally bioavailable inhibitor of histone deacetylases (HDACs) with potential antineoplastic activity. Resminostat binds to and inhibits HDACs leading to an accumulation of highly acetylated histones. This may result in an induction of chromatin remodeling, inhibition of the transcription of tumor suppressor genes, inhibition of tumor cell division and the induction of tumor cell apoptosis. HDACs, upregulated in many tumor types, are a class of enzymes that deacetylate chromatin histone proteins.;

UNII : 1578EUB98L;

InChIKey : FECGNJPYVFEKOD-VMPITWQZSA-N;

CAS number : 864814-88-0; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 864814-88-0 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : 4SC-201;

Chemical formula : C16H19N3O4S;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.